Ma Songjiang, President of Gyre Therapeutics, Inc. ($GYRE), made 18 open market sales of company shares over the past year, totaling nearly $298,000. His most recent sale occurred on May 28, 2025. These sales rank 7,576th among nearly 12,000 individual insiders, well below the average sale amount of $8.6 million across 6.4 transactions. Ma Songjiang recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.28 | 2,806,642.0000 | 102,293,526 | 0.07% | 0.00% |
| May 28, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 558 | $10.07 | 2,806,084.0000 | 102,293,526 | 0.02% | 0.00% |
| May 22, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.97 | 2,808,824.0000 | 102,293,526 | 0.07% | 0.00% |
| May 23, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 182 | $10.24 | 2,808,642.0000 | 102,293,526 | 0.01% | 0.00% |
| May 20, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.25 | 2,812,824.0000 | 102,293,526 | 0.07% | 0.00% |
| May 21, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.83 | 2,810,824.0000 | 102,293,526 | 0.07% | 0.00% |
| May 16, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.31 | 2,816,824.0000 | 102,293,526 | 0.07% | 0.00% |
| May 19, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.11 | 2,814,824.0000 | 102,293,526 | 0.07% | 0.00% |
| May 14, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 20 | $11.30 | 2,820,824.0000 | 102,293,526 | 0.00% | 0.00% |
| May 15, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.68 | 2,818,824.0000 | 102,293,526 | 0.07% | 0.00% |
| May 12, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.56 | 2,822,844.0000 | 102,293,526 | 0.07% | 0.00% |
| May 13, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.37 | 2,820,844.0000 | 102,293,526 | 0.07% | 0.00% |
| March 21, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 174 | $10.00 | 2,824,844.0000 | 102,293,526 | 0.01% | 0.00% |
| March 19, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.13 | 2,827,018.0000 | 102,293,526 | 0.07% | 0.00% |
| March 20, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.09 | 2,825,018.0000 | 102,293,526 | 0.07% | 0.00% |
| March 17, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.09 | 2,829,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 18, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 242 | $10.24 | 2,829,018.0000 | 102,293,526 | 0.01% | 0.00% |
| March 13, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.80 | 2,833,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 14, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.31 | 2,831,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 11, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.40 | 2,837,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 12, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.74 | 2,835,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 7, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 53 | $13.03 | 2,843,207.0000 | 102,293,526 | 0.00% | 0.00% |
| March 7, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 41 | $12.14 | 2,843,166.0000 | 102,293,526 | 0.00% | 0.00% |
| March 7, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1906 | $10.13 | 2,841,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 10, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.14 | 2,839,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 5, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.98 | 2,845,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 6, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.80 | 2,843,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 3, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.23 | 2,849,260.0000 | 102,293,526 | 0.07% | 0.00% |
| March 4, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.86 | 2,847,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 27, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.33 | 2,853,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 28, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.41 | 2,851,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 25, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.37 | 2,857,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 26, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.63 | 2,855,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 21, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1818 | $11.84 | 2,861,442.0000 | 102,293,526 | 0.06% | 0.00% |
| Feb. 21, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 182 | $12.60 | 2,861,260.0000 | 102,293,526 | 0.01% | 0.00% |
| Feb. 24, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1813 | $10.60 | 2,859,447.0000 | 102,293,526 | 0.06% | 0.00% |
| Feb. 24, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 187 | $11.52 | 2,859,260.0000 | 102,293,526 | 0.01% | 0.00% |
| Feb. 19, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.29 | 2,865,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 20, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.40 | 2,863,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 14, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.94 | 2,869,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 18, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.49 | 2,867,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 12, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.49 | 2,873,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 13, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.69 | 2,871,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 10, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.90 | 2,877,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 11, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1878 | $11.52 | 2,875,260.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 7, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.16 | 2,879,158.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 6, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.85 | 2,881,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 4, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.62 | 2,885,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 5, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1980 | $12.39 | 2,883,158.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 5, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 20 | $12.84 | 2,883,138.0000 | 102,293,526 | 0.00% | 0.00% |
| Jan. 31, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.51 | 2,889,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Feb. 3, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.47 | 2,887,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 29, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.43 | 2,893,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 30, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.37 | 2,891,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 27, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.18 | 2,897,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 28, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.51 | 2,895,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 23, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.49 | 2,901,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 24, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.89 | 2,899,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 21, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.85 | 2,905,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 22, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.63 | 2,903,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 16, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.71 | 2,909,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 17, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.72 | 2,907,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 14, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.39 | 2,913,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 15, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.85 | 2,911,138.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 10, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1057 | $10.02 | 2,915,194.0000 | 102,293,526 | 0.04% | 0.00% |
| Jan. 13, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 56 | $10.10 | 2,915,138.0000 | 102,293,526 | 0.00% | 0.00% |
| Jan. 3, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 833 | $11.85 | 2,918,467.0000 | 102,293,526 | 0.03% | 0.00% |
| Jan. 6, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 941 | $10.16 | 2,917,526.0000 | 102,293,526 | 0.03% | 0.00% |
| Jan. 7, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1275 | $10.02 | 2,916,251.0000 | 102,293,526 | 0.04% | 0.00% |
| Jan. 3, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1167 | $11.03 | 2,919,300.0000 | 102,293,526 | 0.04% | 0.00% |
| Jan. 2, 2025 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.40 | 2,920,467.0000 | 102,293,526 | 0.07% | 0.00% |
| Jan. 3, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 833 | $11.85 | 2,918,467.0000 | 65,831,675 | 0.03% | 0.00% |
| Dec. 31, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.30 | 2,922,467.0000 | 102,640,373 | 0.07% | 0.00% |
| Dec. 30, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.50 | 2,924,467.0000 | 102,640,373 | 0.07% | 0.00% |
| Dec. 26, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1644 | $12.62 | 2,928,823.0000 | 102,640,373 | 0.06% | 0.00% |
| Dec. 26, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 356 | $13.05 | 2,928,467.0000 | 102,640,373 | 0.01% | 0.00% |
| Dec. 27, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $12.58 | 2,926,467.0000 | 102,640,373 | 0.07% | 0.00% |
| Dec. 23, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1704 | $12.24 | 2,932,763.0000 | 102,640,373 | 0.06% | 0.00% |
| Dec. 23, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 296 | $12.44 | 2,932,467.0000 | 102,640,373 | 0.01% | 0.00% |
| Dec. 24, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $11.93 | 2,930,467.0000 | 102,640,373 | 0.07% | 0.00% |
| Dec. 19, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.82 | 2,936,467.0000 | 102,640,373 | 0.07% | 0.00% |
| Dec. 20, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 2000 | $10.90 | 2,934,467.0000 | 102,640,373 | 0.07% | 0.00% |
| Dec. 18, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1571 | $11.17 | 2,938,896.0000 | 102,640,373 | 0.05% | 0.00% |
| Dec. 18, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 429 | $12.11 | 2,938,467.0000 | 102,640,373 | 0.01% | 0.00% |
| Dec. 17, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 788 | $11.23 | 2,940,467.0000 | 102,640,373 | 0.03% | 0.00% |
| Dec. 17, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | S | Common Stock | 1212 | $10.94 | 2,941,255.0000 | 102,640,373 | 0.04% | 0.00% |
| Aug. 14, 2024 | GYRE THERAPEUTICS, INC. | $GYRE | Ma Songjiang | President | A | Stock Option (Right to Buy) | 26000 | $0.00 | 26,000.0000 | 65,831,675 | 9999.99% | 0.04% |